Madara Auzenbaha

Medicine & Life Sciences

1. Latvia 100%
2. Phenylketonurias 35%
3. Genes 27%
4. Precursor Cell Lymphoblastic Leukemia-Lymphoma 27%
5. Neonatal Screening 25%
6. Spinal Muscular Atrophy 18%
7. Hepatolenticular Degeneration 17%
8. Type 2 Crigler Najjar syndrome 17%
9. Genetic Testing 16%
10. Crigler-Najjar Syndrome 15%
11. Ornithine Carbamoyltransferase Deficiency Disease 11%
12. Mutation 10%
13. Phenylalanine 10%
14. Leigh Disease 10%
15. Wiskott-Aldrich Syndrome 10%
16. Noonan Syndrome 10%
17. Alleles 10%
18. Mucopolysaccharidosis I 9%
19. Nuchal Translucency Measurement 9%
20. Phenotype 9%
21. Child 9%
22. Tooth 9%
23. DNA 9%
24. Cerebellar Diseases 9%
25. Lymphoproliferative Disorders 9%
26. Population 9%
27. Enzyme Replacement Therapy 9%
28. Chemical and Drug Induced Liver Injury 9%
29. Latent Tuberculosis 9%
30. Interleukin-15 8%
31. Adenosine Deaminase 8%
32. Pregnancy 8%
33. B-Lymphoid Precursor Cells 8%
34. Live Birth 8%
35. Sweat 8%
36. Ornithine Carbamoyltransferase 8%
37. Genetic Variation 8%
38. Lymphocyte Subsets 7%
39. Natural Killer Cells 7%
40. Intellectual Disability 7%
41. Exons 7%
42. University Hospitals 7%
43. Trypsinogen 7%
44. Severe combined immunodeficiency due to adenosine deaminase deficiency 7%
45. Chronic Hepatitis C 7%
46. Oral Health 7%
47. Prenatal Diagnosis 7%
48. Pregnancy Outcome 6%
49. X Chromosome Inactivation 6%
50. Cystic Fibrosis 6%